New feature helps clinical trial research sites and sponsors more accurately and efficiently achieve IRS tax compliance while maintaining confidentiality and privacy Greenphire, the global leader in financial software for clinical trials, announced today that it has...
Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company developing novel antibacterials to treat serious drug-resistant infections, today announced the initiation of the ATTACK (Acinetobacter Treatment Trial Against Colistin)...
A large clinical trial “RELIEVE-IBS-D” for patients with diarrhoea predominant IBS (IBS-D) included in the National Institute for Health Research portfolio has started recruitment in England. The trial is using some of the latest research technologies to...
Small NIH clinical trial conducted in partnership with AstraZeneca. A drug approved to treat a severe form of asthma dramatically improved the health of people with rare chronic immune disorders called hypereosinophilic syndromes (HES) in whom other treatments were...
Hemispherx today announced active initiation of a clinical trial sponsored by Roswell Park Comprehensive Cancer Center (Roswell Park) in Buffalo, N.Y. evaluating Hemispherx’ experimental drug Ampligen® (rintatolimod), a dsRNA TLR3 agonist, in combination with Merck’s...
BriaCell Therapeutics and Incyte have formed a non-exclusive clinical trial collaboration to evaluate the effects of combinations of novel clinical candidates Under the agreement, Incyte will provide compounds from its development portfolio, including INCMGA0012, an...
Email
Text